Kronik Öksürük Sebebi, Nadir Görülen Bir Endobronşiyal Lezyon: Lenfoma

Year 2024, , 442 - 444, 19.09.2024

İlknur Kaya , Feride Marım , Şebnem Emine Parspur , Ümran Toru Erbay

https://doi.org/10.33631/sabd.1366389

Abstract

Non-Hodgkin lenfomalar, B hücreleri, T hücreleri ve natural killer hücrelerinden oluşan lenfoid dokulardan, esas olarak lenf düğümlerinden kaynaklanan tümörlerdir. Extranodal lenfomalar da vücudun herhangi bir organında görülebilir ve endobronşiyal yerleşim oldukça nadir görülmektedir. Öksürük uzun sürdüğü zaman hastanın yaşam kalitesini bozan bir durumdur. 8 haftayı geçen öksürük kronik öksürük olarak adlandırılmaktadır. Kronik öksürük nedenleri çok fazladır ve bazen tanısı zor koyulabilmektedir. İlk etapta yapılan tetkikler ile tanıya gitmek zor olabilmektedir. Tanı aşamasında basamaklı yaklaşım yapılması gerekmektedir. Biz burada medikal tedaviye rağmen geçmeyen öksürük nedeni ile tarafımıza başvuran ve yapılan tetkikler sonrasında lenfoma tanısı alan bir hastamızı, endobronşiyal lenfomaların nadir görülmesi sebebi ile sunmayı amaçladık.

Keywords

bronkoskopi, lenfoma, öksürük

The Cause of Chronic Cough A Rare Endobronchial Lesion: Lymphoma

Abstract

Non-Hodgkin lymphomas are tumors that originate from lymphoid tissues, mainly lymph nodes, consisting of B cells, T cells and natural killer cells. Extranodal lymphomas can also occur in any organ of the body, and endobronchial localization is extremely rare. Cough is a condition that impairs the patient's quality of life when it lasts for a long time. Cough exceeding 8 weeks is called chronic cough. The causes of chronic cough are many and sometimes it can be difficult to diagnose. It can be difficult to make a diagnosis with the tests performed in the first place. A stepwise approach is required at the diagnosis stage. We have presented here a patient who was diagnosed with lymphoma after the examinations, who was admitted to us with a cough that did not resolve despite medical treatment, due to the rare occurrence of endobronchial lymphomas.

Keywords

Bronchoscopy, lymphoma, cough

References

• William J, Variakojis D, Yeldandi A, Raparia K. Lymphoproliferative neoplasms of the lung: A Review. Arch Pathol Lab Med. 2013; 137(3): 382-91.
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer Journal for Clinicians. 2018; 68(6): 394-424.
• D'amore F, Christensen BE, Brincker H, Pedersen NT, Thorling K, Hastrup J, et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. European Journal of Cancer. 1991; 27(10): 1201-8.
• Economopoulos T, Asprou N, Stathakis N, Papageorgiou E, Dervenoulas J, Xanthaki K, et al. Primary extranodal non Hodgkin's lymphoma in adults: clinico pathological and survival characteristics. Leukemia Lymphoma. 1996; 21(1-2): 131-6.
• Economopoulos T, Papageorgiou S, Rontogianni D, Kaloutsi V, Fountzilas G, Tsatalas C, et al. Multifocal extranodal non-Hodgkin lymphoma: a clinicopathological study of 37 cases in Greece, a Hellenic Cooperative On-cology Group study. Oncologist. 2005; 10(9): 734-8.
• Pajares V, Torrego A, Granell M, Szafranska M, Mozos A, Puzo C. Recurrent endobronchial diffuse large B-cell lymphoma. Diagnosed by Cryoprobe. Archivos de Bronconeumolgia. 2013; 49(5): 210-2.
• Berkman N, Breuer R, Kramer MR, Polliack A. Pulmonary involvement in lymphoma. Leukemia Lymphoma. 1996; 20(3-4): 229-37.
• Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. EurRespir J. 2002; 20: 750-62.
• Ferraro P, Trastek VF, Adlakha H, Deschamps C, Allen MS, Pairolero PC. Primary non-Hodgkin's lymphoma of the lung. Ann Thorac Surg. 2000; 69(4): 993-7.
• Irwin RS, French CL, Chang AB, Altman KW. Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report. Chest. 2018; 153(1): 196.
• Wilson MR, Barrett A, Cheah CY, Eyre TA. How I manage mantle cell lymphoma: indolent versus aggressive disease. Br J Haematol. 2023; 201(2): 185-98.